ACIU represents excellent non-commercial production unit approved by National Regulatory Agency for development and production of advanced therapy medicinal products (ATMP) including dendritic cells (DB), activated expanded lymphocytes (AEL), and mesenchymal stromal cells (MSC). The ACIU team consists of experts with experience in pharmaceutical manufacture, with expertise in cell biology and immunology, and/or in diagnostic methods.